Objectives Extra-criteria manifestations of antiphospholipid syndrome (APS) might impact on
prognosis and morbidity of the disease. In this study, we aimed to evaluate a population of …

Abstract Purpose of Review Antiphospholipid syndrome (APS) is a clinical disorder
characterised by thrombosis and/or pregnancy morbidity in the persistence of …

Abstract Purpose of the Review To review the available evidence on the management of a
variety of non-criteria manifestations in antiphospholipid syndrome (APS), including valvular …

Background From this retrospective study, we aimed to (1) describe the prevalence and
characteristics of non-criteria features in primary antiphospholipid syndrome (p-APS) and (2) …

The Antiphospholipid syndrome (APS), formerly known as Anticardiolipin or Hughes
syndrome, is a systemic autoimmune disorder characterized by obstetrical complications …

Objective Recently, our group conceived a risk score for clinical manifestations of APS (the
global APS score, or GAPSS) that takes into account the combination of independent …

Objective. The aim of this study was to evaluate the clinical relevance of the global APS
score (GAPSS) in a cohort of primary APS patients. Methods. This study included 62 …

Introduction Antiphospholipid syndrome (APS) is an autoimmune thrombotic disease with
various systemic presentations. This study aimed to identify homogeneous groups of …

Objectives To assess whether patients with antiphospholipid syndrome (APS) and history of
recurrent thrombosis have higher levels of adjusted Global AntiphosPholipid Syndrome …

Objective This study aimed to assess prospectively the role of anti-ß2-glycoprotein I domain I
antibody (aß2GPI-DI) and the Global Antiphospholipid Syndrome Score (GAPSS) in …